The addition of Johnson & Johnson’s single-dose vaccine in the U. S. could spur more Americans to get immunized against Covid-19 and further reduce vaccine hesitancy, polls indicate.
The addition of Johnson & Johnson’s single-dose vaccine in the U. S. could spur more Americans to get immunized against Covid-19 and further reduce vaccine hesitancy, polls indicate.